MYDRANE 0.2mg / 3.1mg / 10mg / ml injectible solution medication leaflet

S01FA56 tropicamide + phenylephrine + lidocaine • Sensory organs | Mydriatics and cycloplegics | Anticholinergics

Tropicamide+phenylephrine+lidocaine is a combination of medications used in ophthalmology for pupil dilation (mydriasis) and local anesthesia during diagnostic or surgical procedures. Tropicamide is a muscarinic receptor antagonist that relaxes the iris muscles, phenylephrine is an alpha-adrenergic agonist that contracts the iris dilator muscles, and lidocaine is a local anesthetic that reduces pain.

This combination is administered as ophthalmic drops, as directed by a physician. It is commonly used in fundus examinations, cataract surgery, or other ophthalmic interventions.

Common side effects include a burning or stinging sensation in the eye, dry eyes, and temporary photophobia. In rare cases, allergic reactions or temporary increases in intraocular pressure may occur.

Tropicamide+phenylephrine+lidocaine is an effective and safe combination for use in ophthalmology, helping to improve patient comfort and facilitate medical procedures.

General data about MYDRANE 0.2mg / 3.1mg / 10mg / ml

Substance: tropicamide + phenylephrine + lidocaine

Date of last drug list: 01-06-2025

Commercial code: W62116005

Concentration: 0.2mg / 3.1mg / 10mg / ml

Pharmaceutical form: injectible solution

Quantity: 20

Product type: original

Price: 802.88 RON

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

Manufacturer: DELPHARM TOURS - FRANTA

Holder: LABORATOIRES THEA S.A.S. - FRANTA

Number: 13579/2020/01

Shelf life: 3 years

Other substances similar to tropicamide + phenylephrine + lidocaine